139 related articles for article (PubMed ID: 37749772)
1. Impact of hospitalization for vaso-occlusive crisis on health-related quality of life in children with sickle cell disease.
Vuong C; Moussa I; van Muilekom MM; Heijboer H; Rettenbacher E; Haverman L; Twisk J; Fijnvandraat K; Eckhardt CL
Pediatr Blood Cancer; 2023 Dec; 70(12):e30691. PubMed ID: 37749772
[TBL] [Abstract][Full Text] [Related]
2. The Burden of Sickle Cell Disease on Children and Their Caregivers: Caregiver Reports of Children's Health-Related Quality of Life and School Experiences, Caregiver Burden, and Their Association with Frequency of Vaso-Occlusive Crises.
Campbell A; Rizio AA; McCausland KL; Iorga S; Yen GP; Paulose J; Lee S
Patient Relat Outcome Meas; 2023; 14():369-381. PubMed ID: 38046665
[TBL] [Abstract][Full Text] [Related]
3. A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease.
Zaidi AU; Glaros AK; Lee S; Wang T; Bhojwani R; Morris E; Donohue B; Paulose J; Iorga ŞR; Nellesen D
Orphanet J Rare Dis; 2021 Nov; 16(1):460. PubMed ID: 34727959
[TBL] [Abstract][Full Text] [Related]
4. The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease.
Rizio AA; Bhor M; Lin X; McCausland KL; White MK; Paulose J; Nandal S; Halloway RI; Bronté-Hall L
Qual Life Res; 2020 Jun; 29(6):1533-1547. PubMed ID: 31933113
[TBL] [Abstract][Full Text] [Related]
5. Predictors of health-related quality of life in a large cohort of adult patients living with sickle cell disease in France: the DREPAtient study.
Yaya I; Pourageaud A; Derbez B; Odièvre MH; Oudin Doglioni D; Podevin M; Thomas G; Yombo-Kokule L; Godart C; Lepetit M; Cassubie-Mercier T; Galacteros F; Chassany O;
Front Public Health; 2024; 12():1374805. PubMed ID: 38832226
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
[TBL] [Abstract][Full Text] [Related]
7. Neuropathic Pain in Children with Sickle Cell Disease: The Hidden Side of the Vaso-Occlusive Crisis.
Sigalla J; Duparc Alegria N; Le Roux E; Toumazi A; Thiollier AF; Holvoet L; Benkerrou M; Dugue S; Koehl B
Children (Basel); 2021 Jan; 8(2):. PubMed ID: 33530318
[TBL] [Abstract][Full Text] [Related]
8. Association Between Vaso-Occlusive Crises and Opioid Prescriptions Among Patients with Sickle Cell Disease: A Retrospective Claims-Based Study.
Kang HA; Barner JC; Richards KM; Bhor M; Paulose J; Kutlar A
J Health Econ Outcomes Res; 2020; 7(1):94-101. PubMed ID: 36873574
[No Abstract] [Full Text] [Related]
9. Validation of patient-reported vaso-occlusive crisis day as an endpoint in sickle cell disease studies.
Coyne KS; Currie BM; Callaghan M; Wyrwich KW; Pease S; Baker CL; Arkin S; Pittman DD
Eur J Haematol; 2022 Sep; 109(3):226-237. PubMed ID: 35569114
[TBL] [Abstract][Full Text] [Related]
10. Association between Vaso-occlusive Crises and Opioid Prescriptions among Patients with Sickle Cell Disease: A Retrospective Claims-based Study.
Kang HA; Barner JC; Richards KM; Bhor M; Paulose J; Kutlar A
J Health Econ Outcomes Res; 2020; 7(1):94-101. PubMed ID: 32685602
[TBL] [Abstract][Full Text] [Related]
11. Vaso-occlusive crises and costs of sickle cell disease in patients with commercial, Medicaid, and Medicare insurance - the perspective of private and public payers.
Shah NR; Bhor M; Latremouille-Viau D; Kumar Sharma V; Puckrein GA; Gagnon-Sanschagrin P; Khare A; Kumar Singh M; Serra E; Davidson M; Xu L; Guerin A
J Med Econ; 2020 Nov; 23(11):1345-1355. PubMed ID: 32815766
[TBL] [Abstract][Full Text] [Related]
12. The impact of vaso-occlusive crises and disease severity on quality of life and productivity among patients with sickle cell disease in the US.
Shafrin J; Thom HHZ; Keeney E; Gaunt DM; Zhao LM; Bhor M; Rizio AA; Bronté-Hall L; Shah N
Curr Med Res Opin; 2021 May; 37(5):761-768. PubMed ID: 33686891
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of treatment patterns, healthcare resource utilization and cost of illness for sickle cell disease in Ghana: a private medical insurance claims database study.
Marfo K; Dei-Adomakoh Y; Segbefia C; Dwomoh D; Edgal A; Ampah N; Ramachandrachar BC; Subramanyam K; Natarajan A; Egbujo O; Ataga KI
BMC Health Serv Res; 2023 Sep; 23(1):1018. PubMed ID: 37735428
[TBL] [Abstract][Full Text] [Related]
14. Effect of Weather on Frequency of Vaso-Occlusive Crisis in Children With Sickle Cell Disease.
Almuqamam M; Ahuja K; Wassef I; Kilaikode S; Sedrak A
Cureus; 2021 Aug; 13(8):e17254. PubMed ID: 34540479
[TBL] [Abstract][Full Text] [Related]
15. Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States.
Udeze C; Evans KA; Yang Y; Lillehaugen T; Manjelievskaia J; Mujumdar U; Li N; Andemariam B
Adv Ther; 2023 Aug; 40(8):3543-3558. PubMed ID: 37332020
[TBL] [Abstract][Full Text] [Related]
16. Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study.
Finkelstein Y; Schechter T; Garcia-Bournissen F; Kirby M; Nurmohamed L; Juurlink DN; Blanchette V; Koren G
Clin Ther; 2007 Dec; 29(12):2738-43. PubMed ID: 18201591
[TBL] [Abstract][Full Text] [Related]
17. Medical Resource Use and Costs of Treating Sickle Cell-related Vaso-occlusive Crisis Episodes: A Retrospective Claims Study.
Shah N; Bhor M; Xie L; Paulose J; Yuce H
J Health Econ Outcomes Res; 2020; 7(1):52-60. PubMed ID: 32685598
[TBL] [Abstract][Full Text] [Related]
18. Treatment Options That Reduce the Duration of Sickle Cell Vaso-Occlusive Crises: A Systematic Review.
Akindele AO; Jalkh AP; Eastmond AK; Shetty C; Rizvi SMHA; Sharaf J; Williams KD; Tariq M; Acharekar MV; Guerrero Saldivia SE; Unnikrishnan SN; Chavarria YY; Balani P
Cureus; 2022 Aug; 14(8):e28337. PubMed ID: 36176876
[TBL] [Abstract][Full Text] [Related]
19. Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.
Deux JF; Audard V; Brugières P; Habibi A; Manea EM; Guillaud-Danis C; Godeau B; Galactéros F; Stehlé T; Lang P; Grimbert P; Audureau E; Rahmouni A; Bartolucci P
Am J Kidney Dis; 2017 Jan; 69(1):51-59. PubMed ID: 27663041
[TBL] [Abstract][Full Text] [Related]
20. Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome.
Morris CR; Kuypers FA; Larkin S; Vichinsky EP; Styles LA
J Pediatr Hematol Oncol; 2000; 22(6):515-20. PubMed ID: 11132219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
